ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Olon, an Italian pharmaceutical chemical maker, has acquired GTP Bioways, a French biotechnology services firm. GTP operates four sites across France manufacturing biologics, antibody-drug conjugates (ADCs), and nanodrugs. The company also provides fill-and-finish and analytical development services. Olon says the purchase will help it increase the production of ADCs, a class of oncology drug that is seeing growing investor attention.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter